Navigation Links
VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
Date:10/19/2007

aniasis.

Further information about VioQuest can be found at http://www.vioquestpharm.com.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties that could cause VioQuest's actual results and experiences to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as anticipates, expects, plans, believes, intends, and similar words or phrases. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. In addition, this press release also includes forward-looking statements regarding the timing, progress and results of the clinical development, regulatory processes, potential clinical trial initiations, potential IND and NDA filings and commercialization efforts of VioQuest's drug development product candidates. These statements are subject to various risks and uncertainties and include the possibility that the results of clinical trials will not support VioQuest's claims, the possibility that VioQuest's development efforts relating to its product candidates, including Lenocta(TM), VQD-002, and Xyfid(TM) will not be successful, the inability to obtain regulatory approval of VioQuest's product candidates, VioQuest's reliance on third-party researchers to develop its product candidates, its lack of experience in developing and commercializing pharmaceutical products, and the possibility that its licenses to develop and commercialize its product candidates may be terminated. Additional risks are described in VioQuest's Annual Report on Form 10-KSB for the year ended December 31, 2006. VioQuest assumes no obligation and does not intend to upda
'/>"/>

SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... 19, 2014 The “Human Insulin ... Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, ... NovoRapid, Novomix, Tresiba, Others) - Forecast to 2018” ... restraints, challenges, opportunities, current market trends, and strategies ... the estimates and forecasts of the revenue and ...
(Date:10/18/2014)... October 18, 2014 The Asia-Pacific hardware ... market in Asia-Pacific with analysis and forecast of revenue. ... is expected to reach $51,362.6 million by 2018, at ... Browse through the TOC of the Asia-Pacific hardware encryption ... analysis provided. This also provides a glimpse of the ...
(Date:10/18/2014)... According to a new market research report ... Global Trends & Forecasts up till 2017”, hydraulic fracturing ... This value is expected to increase from $40 billion ... CAGR during the same period. North America is expected ... terms of hydraulic horse power supplied by the year ...
(Date:10/17/2014)... journey through the looking-glass to Wonderland, mirrors in the ... ways, including a new class of mirror that works ... The Optical Society,s (OSA) new high-impact journal ... time, a new type of mirror that forgoes a ... by using an unusual magnetic property of a non-metallic ...
Breaking Biology Technology:Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4Magnetic mirrors enable new technologies by reflecting light in uncanny ways 2Magnetic mirrors enable new technologies by reflecting light in uncanny ways 3Magnetic mirrors enable new technologies by reflecting light in uncanny ways 4
... Energy, manufacturer of Reuter Stokes radiation detection equipment, has ... and software associated with the SNS 8Pack neutron detector ... neutron detectors developed at Oak Ridge National Laboratory. ... system that was developed for the Department of Energy,s ...
... June 3 Xceed Molecular, a pioneer ... has granted Gen-Probe Incorporated (Nasdaq: GPRO ... use Xceed,s novel Flow-Thru Chip,technology. Gen-Probe expects ... multiplexed molecular-diagnostics products. Gen-Probe is a,global leader ...
... June 3 ViroPharma Incorporated,(Nasdaq: VPHM ) ... officer of ViroPharma, will present at the Goldman ... PDT on Tuesday, June 10,2008. The conference is ... Point, CA., ViroPharma also announced that William ...
Cached Biology Technology:GE Energy to market SNS-developed detector electronics system 2Xceed Molecular Grants Gen-Probe License to Xceed's Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics 2ViroPharma to Present at Two Upcoming Healthcare Conferences 2
(Date:10/15/2014)... assess the pandemic risk from strains of influenza virus ... allow ourselves to become complacent that the most substantial ... scientists. , Influenza pandemics arise when a new virus ... widespread immunity – spreads in the human population. There ... years, the worst of which – the 1918 Spanish ...
(Date:10/15/2014)... bacterial pneumonia in female mice to an enzyme activated ... naturally more resistant to respiratory infections than males. Now, ... resistance to bacterial pneumonia in female mice is linked ... also show that this enzyme is ultimately activated by ... The team, lead by Professor Lester Kobzik at the ...
(Date:10/14/2014)... N.C. – Like discriminating thieves, prostate cancer tumors scavenge ... the body. But such avarice may be a fatal ... a way to kill prostate cancer cells by delivering ... selectively destroys the diseased cells brimming with the mineral, ... uses two drugs already commercially available for other uses, ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Prostate cancer's penchant for copper may be a fatal flaw 2
... N.Y., won the ninth-annual IEEE-USA Best Communications System ... Competition National Finals on Wednesday. Farnsworth ... communications system" at the Hyatt Regency Washington on ... Zubin Mukerjee, Abigail Schooner and Joseph Sipzner; engineer-mentor ...
... colleagues in the palaeontology and biomechanics research group have reconstructed ... (Stan at the Manchester Museum and the Museum of the ... Strutiomimum sedens and an Edmontosaurus annectens . ... of Science journal PLoS ONE today (19th February ...
... senior, has been named the first Churchill Scholar at the ... a one-year graduate program at Cambridge University, where he will ... Juneja, a mechanical engineering major, has maintained a near ... Last spring when he was about to graduate his academic ...
Cached Biology News:New York, Florida schools win awards at national student competition 2'Fattysaurus' or 'thinnysaurus'? How dinosaurs measure up with laser imaging 2'Fattysaurus' or 'thinnysaurus'? How dinosaurs measure up with laser imaging 3UC San Diego senior named Churchill Scholar for extraordinary undergraduate research 2UC San Diego senior named Churchill Scholar for extraordinary undergraduate research 3
...
... to Decorin ( Abpromise for ... Antigen: Synthetic peptide: IGPEVPDDRDFEPS conjugated ... 6-19 of Human Decorin (fragment 36-49 ... II). Entrez GeneID: ...
... Introducing the NEW VSOS-4P, all Programmable and Digital ... has now been redesigned to make every day ... a Programmable memory for up to 4 different ... entry of your program. Furthermore, the VSOS-4P has ...
... Antibody Validation Service enables early selection ... development by providing quantitative data for ... of each antibody. Furthermore quantitative antibody ... off-target activity of your antibodies., The ...
Biology Products: